An EVD or external ventricular drain, is a device used in neurosurgery to relieve intracranial pressure (ICP) resulting from a disturbance in cerebrospinal fluid (CSF) drainage due to tumors, cysts, bleeding, infection, hydrocephalus, and trauma. Existing EVD’s are manually assembled so as to insure appropriate drainage and ICP. Unfortunately, these systems are labor intensive and require full time monitoring by the medical staff.

Using today’s electronic devices and sensors, we have designed an EVD that can provide a completely autonomous solution while providing accuracy and repeatability.

After a venomous snake bite time is of the essence. We enable immediate bite treatment that delays the neurotoxic and tissue damaging effects of the venom, allowing time to seek help.

University of Arizona researchers have developed an affordable precision brace technology for carpal tunnel relief, delivering targeted compression and customized comfort to transform hand health.

Aquaculture is the fastest growing food production sector in the world yet suffers 10% annual losses due to diseases (that’s ~$25 billion lost). Tools for control of these diseases are insufficient or too expensive. Efficacious and inexpensive solutions to address aquaculture disease are an industry priority. Our viral vector platform can be a solution – flexible and customizable to address finfish and crustacean diseases. It can be delivered orally to lower cost and make it more universally applicable to the industry.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.

Stratofly Research seeks to deploy autonomous constellations of our patent-pending altitude-controlled high-altitude balloons (HABs) to collect higher fidelity in-situ atmospheric weather data in data-sparse areas such as over oceans, to improve weather forecasting.

Two of the HABs we manufacture do not require a lighter-than-air, reducing cost and complexity. Altitude-controlled HABs can autonomously adjust altitude to “ride” opposing winds at different altitudes for station-keeping over regions of interest and performing trajectory maneuvers.

With a 10x cost savings compared with current larger altitude-controlled HABs, these small low-cost HABs allow customers to deploy constellations of smaller payloads in the stratosphere, rather than one primary payload.

Many cancer drugs suffer from severe adverse effects due to acute high exposure and inadequate distribution to tumors. This technology provides a vehicle for the preferred delivery of existing and approved drugs to tumor environments and local release of the active agent, thereby focusing exposure to tissues in need and reducing unwanted side effects.

Innovations in healthcare are reshaping how we diagnose gynecologic conditions like endometrial cancer, endometriosis and adenomyosis. Our groundbreaking approach focuses on non-invasive sampling coupled with advanced biomarker analysis for early detection, especially among underserved populations. By leveraging integrated technologies, we aim to revolutionize women’s health, offering timely diagnoses, improving outcomes, and ultimately saving lives. Join us in our mission to make early detection of gynecologic conditions accessible to all women, regardless of their background or resources.